| Dear VPHi members, The European Medicine Agency has opened an online consultation on their proposed strategic vision on Regulatory Science to 2025.
The purpose of this public consultation is to seek views on EMA’s strategy and whether it meets stakeholders’ needs. By highlighting where we see the need as greatest, there is the opportunity to jointly shape a vision for regulatory science that will in turn feed into the wider EU network strategy in the period 2020-25.
This initiative is very relevant for the VPHi community. For this reason, we highly recommend you to respond to the consultation, which can be found here: https://ec.europa.eu/eusurvey/runner/EMARS2025PublicConsultation2019
To facilitate the process and ensure we give a strong common response to the consultation, we have drafted some suggestions for responses to the questionnaire. You can find here the document to use at your convenience: https://tinyurl.com/VPHi-responses-EMAconsultation Of course you are very welcome to provide your own insights and opinions.
The questionnaire will remain open until the 30th of June.
Alongside this initiative, we have also drafted an open letter, which will be sent to Prof Guido Rasi - the Director of EMA to specifically stress the value of in silico methods, which are not only related to the reduction of animal experimentation, as described in their strategy, but can also be applied for a number of other cases, such as the reduction, refinement, and even replacement of clinical trials. If you still haven't done it, you can sign the petition from this link:
https://www.change.org/p/guido-rasi-foster-adoption-of-in-silico-trials-through-ema-s-strategy-on-regulatory-science-to-2025
We are available in case you have any questions. Thank you for your collaboration. Best regards Martina ---- | 
